Tag Archives: Advanced

Advanced Cancers Are Emerging, Doctors Warn, Citing Pandemic Drop in Screenings

The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Rollout Advertisement Continue reading the main story Supported by Continue reading the main story Advanced Cancers Are Emerging, Doctors Warn, Citing Pandemic Drop in Screenings Appointments for mammograms and other tests to detect potential cancers were canceled during lockdowns,… Read More »

Soft Electronics for Advanced Heart Catheters

Researchers at George Washington University and Northwestern University have developed a new class of soft devices that can provide new functionality for catheters used in cardiac procedures. The new materials are soft electronics, including stretchable sensors and actuators, that when applied to the surface of a catheter system, could greatly assist in diagnosing and treating… Read More »

FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers

FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers Print this page INDIANAPOLIS, May 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Retevmo™ (selpercatinib, 40 mg & 80 mg capsules), the first therapy specifically indicated for the treatment of adult patients with… Read More »

FDA Approves Padcev (enfortumab vedotin-ejfv) for Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer

FDA Approves Padcev (enfortumab vedotin-ejfv) for Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer Print this page TOKYO and BOTHELL, Wash., Dec. 18, 2019 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Padcev™ for the… Read More »